NO20063805L - Hoyrent butokonazolnitrat med spesifisert partikkelstorrelse og en fremgangsmate for fremstilling derav - Google Patents

Hoyrent butokonazolnitrat med spesifisert partikkelstorrelse og en fremgangsmate for fremstilling derav

Info

Publication number
NO20063805L
NO20063805L NO20063805A NO20063805A NO20063805L NO 20063805 L NO20063805 L NO 20063805L NO 20063805 A NO20063805 A NO 20063805A NO 20063805 A NO20063805 A NO 20063805A NO 20063805 L NO20063805 L NO 20063805L
Authority
NO
Norway
Prior art keywords
high purity
particle size
preparation
specified particle
butoconazole nitrate
Prior art date
Application number
NO20063805A
Other languages
English (en)
Inventor
Laszlo Czibula
Laszlo Dobay
Eva Werkne Papp
Judit Nagyne Bagdy
Ferenc Sebok
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO20063805L publication Critical patent/NO20063805L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)

Abstract

Ett mål med oppfinnelsen er høyrent buto-konazolnitrat med formel (I). (I) inneholder maksimum 0,1 vekt% kjemiske urenheter, hvor minst 95% av substanspartiklene er under 75 (m i diameter, mens minst 99% av partiklene er under 250 (m i diameter, og en fremgangsmåte for fremstilling av det. Et farmasøytisk preparat omfattende som aktiv ingrediens, høyrent butokonazolnitrat med spesifisert partikkel-størrelse i en blanding med kjente hjelpestoffer er også innenfor rammen av oppfinnelsen.
NO20063805A 2004-01-27 2006-08-25 Hoyrent butokonazolnitrat med spesifisert partikkelstorrelse og en fremgangsmate for fremstilling derav NO20063805L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0400270A HUP0400270A3 (en) 2004-01-27 2004-01-27 High purity butoconazole nitrate having a predetermined particle size and process for the production of the same
PCT/HU2005/000002 WO2005070897A1 (en) 2004-01-27 2005-01-25 High purity butoconazole nitrate with specified particle size and a process for preparation thereof

Publications (1)

Publication Number Publication Date
NO20063805L true NO20063805L (no) 2006-08-25

Family

ID=89981937

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063805A NO20063805L (no) 2004-01-27 2006-08-25 Hoyrent butokonazolnitrat med spesifisert partikkelstorrelse og en fremgangsmate for fremstilling derav

Country Status (9)

Country Link
US (1) US7625935B2 (no)
EP (2) EP1903035A3 (no)
JP (1) JP4795973B2 (no)
DE (1) DE602005015417D1 (no)
EA (1) EA009238B1 (no)
HU (1) HUP0400270A3 (no)
NO (1) NO20063805L (no)
UA (1) UA87674C2 (no)
WO (1) WO2005070897A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102649796A (zh) * 2011-02-24 2012-08-29 四川滇虹医药开发有限公司 一种硝酸布康唑中间体的制备方法
CN105198814B (zh) * 2015-10-09 2018-03-20 株洲千金药业股份有限公司 一种工业化生产硝酸布康唑中间体的方法
CN105218456B (zh) * 2015-10-09 2018-07-03 株洲千金药业股份有限公司 一种工业化生产硝酸布康唑的方法
CN105218455B (zh) * 2015-10-09 2018-07-03 株洲千金药业股份有限公司 一种工业化连续生产硝酸布康唑的方法
CN105198816B (zh) * 2015-10-09 2018-05-01 株洲千金药业股份有限公司 一种工业化生产硝酸布康唑的方法
CN105175341B (zh) * 2015-10-09 2017-12-26 株洲千金药业股份有限公司 一种工业化合成硝酸布康唑中间体的方法
CN105175338B (zh) * 2015-10-09 2018-03-23 株洲千金药业股份有限公司 一种工业化生产硝酸布康唑中间体的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1567431A (en) * 1977-01-10 1980-05-14 Syntex Inc 1-(2-(halophenylthio)-4-(p-chloro- or-flrorophenyl)-n-butyl) imidazoles

Also Published As

Publication number Publication date
JP4795973B2 (ja) 2011-10-19
EA009238B1 (ru) 2007-12-28
EP1903035A3 (en) 2009-01-07
US20080221190A1 (en) 2008-09-11
WO2005070897A1 (en) 2005-08-04
JP2007519699A (ja) 2007-07-19
DE602005015417D1 (de) 2009-08-27
UA87674C2 (ru) 2009-08-10
EP1903035A2 (en) 2008-03-26
EP1709005B1 (en) 2009-07-15
US7625935B2 (en) 2009-12-01
HUP0400270A2 (hu) 2005-12-28
HU0400270D0 (en) 2004-04-28
HUP0400270A3 (en) 2007-09-28
EP1709005A1 (en) 2006-10-11
EA200601373A1 (ru) 2006-12-29

Similar Documents

Publication Publication Date Title
NO20063805L (no) Hoyrent butokonazolnitrat med spesifisert partikkelstorrelse og en fremgangsmate for fremstilling derav
EP3341007B1 (en) Malt1 inhibitors and uses thereof
NO20063517L (no) Ny krystallinsk form v av agomelatin, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
NO20064596L (no) Delta-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
NO20063516L (no) Ny krystallinsk form III av agomelatin, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
WO2006024486A3 (en) Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
NO20063518L (no) Ny krystallinsk form IV av agomelatin, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
NO20064151L (no) Nye forbindelser
PL2018379T3 (pl) Sole skopiny oraz ich zastosowanie w sposobach wytwarzania N-demetylo-tiotropium i bromku tiotropium
UA97351C2 (ru) Производная кумарина, имеющая противоопухолевую активность
TW200640874A (en) &bgr d-crystallind form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
TW200745111A (en) New compounds
NO20050921L (no) Nye fysiologisk aktive substanser
TNSN08173A1 (en) Dispersible tablets comprising deferasirox
UA106759C2 (uk) Спосіб синтезу пірфенідону
JO2937B1 (en) Tight muscles of the peptide vascular tensioner receptor
HK1072009A1 (en) Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof.
MX2013005241A (es) Cristal de derivado de 6,7-insaturado-7-carbamoil morfinano y metodo para producir el mismo.
JPWO2019065928A1 (ja) グリセオフルビン化合物と医薬用途
WO2007075838A3 (en) Pure and stable tiotropium bromide
EA200801508A1 (ru) ВЫСОКОЧИСТЫЙ 17α-ЦИАНОМЕТИЛ-17β-ГИДРОКСИ-ЭСТРА-4,9-ДИЕН-3-ОН И СПОСОБ ЕГО СИНТЕЗА
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
BRPI0517734A (pt) derivados de 1-[(6,7-alcoxiquinoxalinil substituìdo) aminocarbonil]-4- (hetero) arilpiperazina
EP3847175B1 (en) Crystalline forms of a phosphoinositide 3-kinase (pi3k) inhibitor
WO2006014780A3 (en) Methods and compositions for treating or preventing macular-degeneration related disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application